Global Pneumonia Vaccine Market Research Report 2023(Status and Outlook)
Report Overview
Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.
Bosson Research’s latest report provides a deep insight into the global Pneumonia Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pneumonia Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pneumonia Vaccine market in any manner.
Global Pneumonia Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc.
Glaxosmithkline Plc.
Merck & Co., Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Johnson & Johnson
Astellas Pharma Inc.
Astrazeneca Plc.
CSL Limited
Emergent Biosolutions
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biologic
Market Segmentation (by Type)
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
Other
Market Segmentation (by Application)
Pneumonia
Meningitis
Sepsis
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pneumonia Vaccine Market
Overview of the regional outlook of the Pneumonia Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumonia Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.
Bosson Research’s latest report provides a deep insight into the global Pneumonia Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pneumonia Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pneumonia Vaccine market in any manner.
Global Pneumonia Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc.
Glaxosmithkline Plc.
Merck & Co., Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Johnson & Johnson
Astellas Pharma Inc.
Astrazeneca Plc.
CSL Limited
Emergent Biosolutions
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biologic
Market Segmentation (by Type)
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
Other
Market Segmentation (by Application)
Pneumonia
Meningitis
Sepsis
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pneumonia Vaccine Market
Overview of the regional outlook of the Pneumonia Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumonia Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pneumonia Vaccine
1.2 Key Market Segments
1.2.1 Pneumonia Vaccine Segment by Type
1.2.2 Pneumonia Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PNEUMONIA VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pneumonia Vaccine Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Pneumonia Vaccine Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PNEUMONIA VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Pneumonia Vaccine Sales by Manufacturers (2018-2023)
3.2 Global Pneumonia Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.3 Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pneumonia Vaccine Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Pneumonia Vaccine Sales Sites, Area Served, Product Type
3.6 Pneumonia Vaccine Market Competitive Situation and Trends
3.6.1 Pneumonia Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pneumonia Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PNEUMONIA VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Pneumonia Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PNEUMONIA VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PNEUMONIA VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pneumonia Vaccine Sales Market Share by Type (2018-2023)
6.3 Global Pneumonia Vaccine Market Size Market Share by Type (2018-2023)
6.4 Global Pneumonia Vaccine Price by Type (2018-2023)
7 PNEUMONIA VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pneumonia Vaccine Market Sales by Application (2018-2023)
7.3 Global Pneumonia Vaccine Market Size (M USD) by Application (2018-2023)
7.4 Global Pneumonia Vaccine Sales Growth Rate by Application (2018-2023)
8 PNEUMONIA VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Pneumonia Vaccine Sales by Region
8.1.1 Global Pneumonia Vaccine Sales by Region
8.1.2 Global Pneumonia Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Pneumonia Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pneumonia Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pneumonia Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pneumonia Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pneumonia Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc.
9.1.1 Pfizer Inc. Pneumonia Vaccine Basic Information
9.1.2 Pfizer Inc. Pneumonia Vaccine Product Overview
9.1.3 Pfizer Inc. Pneumonia Vaccine Product Market Performance
9.1.4 Pfizer Inc. Business Overview
9.1.5 Pfizer Inc. Pneumonia Vaccine SWOT Analysis
9.1.6 Pfizer Inc. Recent Developments
9.2 Glaxosmithkline Plc.
9.2.1 Glaxosmithkline Plc. Pneumonia Vaccine Basic Information
9.2.2 Glaxosmithkline Plc. Pneumonia Vaccine Product Overview
9.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Product Market Performance
9.2.4 Glaxosmithkline Plc. Business Overview
9.2.5 Glaxosmithkline Plc. Pneumonia Vaccine SWOT Analysis
9.2.6 Glaxosmithkline Plc. Recent Developments
9.3 Merck and Co., Inc.
9.3.1 Merck and Co., Inc. Pneumonia Vaccine Basic Information
9.3.2 Merck and Co., Inc. Pneumonia Vaccine Product Overview
9.3.3 Merck and Co., Inc. Pneumonia Vaccine Product Market Performance
9.3.4 Merck and Co., Inc. Business Overview
9.3.5 Merck and Co., Inc. Pneumonia Vaccine SWOT Analysis
9.3.6 Merck and Co., Inc. Recent Developments
9.4 Sanofi Pasteur
9.4.1 Sanofi Pasteur Pneumonia Vaccine Basic Information
9.4.2 Sanofi Pasteur Pneumonia Vaccine Product Overview
9.4.3 Sanofi Pasteur Pneumonia Vaccine Product Market Performance
9.4.4 Sanofi Pasteur Business Overview
9.4.5 Sanofi Pasteur Pneumonia Vaccine SWOT Analysis
9.4.6 Sanofi Pasteur Recent Developments
9.5 Serum Institute of India Pvt. Ltd.
9.5.1 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Basic Information
9.5.2 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Overview
9.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Market Performance
9.5.4 Serum Institute of India Pvt. Ltd. Business Overview
9.5.5 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine SWOT Analysis
9.5.6 Serum Institute of India Pvt. Ltd. Recent Developments
9.6 Johnson and Johnson
9.6.1 Johnson and Johnson Pneumonia Vaccine Basic Information
9.6.2 Johnson and Johnson Pneumonia Vaccine Product Overview
9.6.3 Johnson and Johnson Pneumonia Vaccine Product Market Performance
9.6.4 Johnson and Johnson Business Overview
9.6.5 Johnson and Johnson Recent Developments
9.7 Astellas Pharma Inc.
9.7.1 Astellas Pharma Inc. Pneumonia Vaccine Basic Information
9.7.2 Astellas Pharma Inc. Pneumonia Vaccine Product Overview
9.7.3 Astellas Pharma Inc. Pneumonia Vaccine Product Market Performance
9.7.4 Astellas Pharma Inc. Business Overview
9.7.5 Astellas Pharma Inc. Recent Developments
9.8 Astrazeneca Plc.
9.8.1 Astrazeneca Plc. Pneumonia Vaccine Basic Information
9.8.2 Astrazeneca Plc. Pneumonia Vaccine Product Overview
9.8.3 Astrazeneca Plc. Pneumonia Vaccine Product Market Performance
9.8.4 Astrazeneca Plc. Business Overview
9.8.5 Astrazeneca Plc. Recent Developments
9.9 CSL Limited
9.9.1 CSL Limited Pneumonia Vaccine Basic Information
9.9.2 CSL Limited Pneumonia Vaccine Product Overview
9.9.3 CSL Limited Pneumonia Vaccine Product Market Performance
9.9.4 CSL Limited Business Overview
9.9.5 CSL Limited Recent Developments
9.10 Emergent Biosolutions
9.10.1 Emergent Biosolutions Pneumonia Vaccine Basic Information
9.10.2 Emergent Biosolutions Pneumonia Vaccine Product Overview
9.10.3 Emergent Biosolutions Pneumonia Vaccine Product Market Performance
9.10.4 Emergent Biosolutions Business Overview
9.10.5 Emergent Biosolutions Recent Developments
9.11 Walvax Biotechnology
9.11.1 Walvax Biotechnology Pneumonia Vaccine Basic Information
9.11.2 Walvax Biotechnology Pneumonia Vaccine Product Overview
9.11.3 Walvax Biotechnology Pneumonia Vaccine Product Market Performance
9.11.4 Walvax Biotechnology Business Overview
9.11.5 Walvax Biotechnology Recent Developments
9.12 Royal (Wuxi) Bio-Pharmaceutical
9.12.1 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Basic Information
9.12.2 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Overview
9.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Market Performance
9.12.4 Royal (Wuxi) Bio-Pharmaceutical Business Overview
9.12.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
9.13 Zhifei Biologic
9.13.1 Zhifei Biologic Pneumonia Vaccine Basic Information
9.13.2 Zhifei Biologic Pneumonia Vaccine Product Overview
9.13.3 Zhifei Biologic Pneumonia Vaccine Product Market Performance
9.13.4 Zhifei Biologic Business Overview
9.13.5 Zhifei Biologic Recent Developments
10 PNEUMONIA VACCINE MARKET FORECAST BY REGION
10.1 Global Pneumonia Vaccine Market Size Forecast
10.2 Global Pneumonia Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pneumonia Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Pneumonia Vaccine Market Size Forecast by Region
10.2.4 South America Pneumonia Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pneumonia Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Pneumonia Vaccine Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Pneumonia Vaccine by Type (2024-2029)
11.1.2 Global Pneumonia Vaccine Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Pneumonia Vaccine by Type (2024-2029)
11.2 Global Pneumonia Vaccine Market Forecast by Application (2024-2029)
11.2.1 Global Pneumonia Vaccine Sales (K MT) Forecast by Application
11.2.2 Global Pneumonia Vaccine Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pneumonia Vaccine
1.2 Key Market Segments
1.2.1 Pneumonia Vaccine Segment by Type
1.2.2 Pneumonia Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PNEUMONIA VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pneumonia Vaccine Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Pneumonia Vaccine Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PNEUMONIA VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Pneumonia Vaccine Sales by Manufacturers (2018-2023)
3.2 Global Pneumonia Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.3 Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pneumonia Vaccine Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Pneumonia Vaccine Sales Sites, Area Served, Product Type
3.6 Pneumonia Vaccine Market Competitive Situation and Trends
3.6.1 Pneumonia Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pneumonia Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PNEUMONIA VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Pneumonia Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PNEUMONIA VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PNEUMONIA VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pneumonia Vaccine Sales Market Share by Type (2018-2023)
6.3 Global Pneumonia Vaccine Market Size Market Share by Type (2018-2023)
6.4 Global Pneumonia Vaccine Price by Type (2018-2023)
7 PNEUMONIA VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pneumonia Vaccine Market Sales by Application (2018-2023)
7.3 Global Pneumonia Vaccine Market Size (M USD) by Application (2018-2023)
7.4 Global Pneumonia Vaccine Sales Growth Rate by Application (2018-2023)
8 PNEUMONIA VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Pneumonia Vaccine Sales by Region
8.1.1 Global Pneumonia Vaccine Sales by Region
8.1.2 Global Pneumonia Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Pneumonia Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pneumonia Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pneumonia Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pneumonia Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pneumonia Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc.
9.1.1 Pfizer Inc. Pneumonia Vaccine Basic Information
9.1.2 Pfizer Inc. Pneumonia Vaccine Product Overview
9.1.3 Pfizer Inc. Pneumonia Vaccine Product Market Performance
9.1.4 Pfizer Inc. Business Overview
9.1.5 Pfizer Inc. Pneumonia Vaccine SWOT Analysis
9.1.6 Pfizer Inc. Recent Developments
9.2 Glaxosmithkline Plc.
9.2.1 Glaxosmithkline Plc. Pneumonia Vaccine Basic Information
9.2.2 Glaxosmithkline Plc. Pneumonia Vaccine Product Overview
9.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Product Market Performance
9.2.4 Glaxosmithkline Plc. Business Overview
9.2.5 Glaxosmithkline Plc. Pneumonia Vaccine SWOT Analysis
9.2.6 Glaxosmithkline Plc. Recent Developments
9.3 Merck and Co., Inc.
9.3.1 Merck and Co., Inc. Pneumonia Vaccine Basic Information
9.3.2 Merck and Co., Inc. Pneumonia Vaccine Product Overview
9.3.3 Merck and Co., Inc. Pneumonia Vaccine Product Market Performance
9.3.4 Merck and Co., Inc. Business Overview
9.3.5 Merck and Co., Inc. Pneumonia Vaccine SWOT Analysis
9.3.6 Merck and Co., Inc. Recent Developments
9.4 Sanofi Pasteur
9.4.1 Sanofi Pasteur Pneumonia Vaccine Basic Information
9.4.2 Sanofi Pasteur Pneumonia Vaccine Product Overview
9.4.3 Sanofi Pasteur Pneumonia Vaccine Product Market Performance
9.4.4 Sanofi Pasteur Business Overview
9.4.5 Sanofi Pasteur Pneumonia Vaccine SWOT Analysis
9.4.6 Sanofi Pasteur Recent Developments
9.5 Serum Institute of India Pvt. Ltd.
9.5.1 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Basic Information
9.5.2 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Overview
9.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Market Performance
9.5.4 Serum Institute of India Pvt. Ltd. Business Overview
9.5.5 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine SWOT Analysis
9.5.6 Serum Institute of India Pvt. Ltd. Recent Developments
9.6 Johnson and Johnson
9.6.1 Johnson and Johnson Pneumonia Vaccine Basic Information
9.6.2 Johnson and Johnson Pneumonia Vaccine Product Overview
9.6.3 Johnson and Johnson Pneumonia Vaccine Product Market Performance
9.6.4 Johnson and Johnson Business Overview
9.6.5 Johnson and Johnson Recent Developments
9.7 Astellas Pharma Inc.
9.7.1 Astellas Pharma Inc. Pneumonia Vaccine Basic Information
9.7.2 Astellas Pharma Inc. Pneumonia Vaccine Product Overview
9.7.3 Astellas Pharma Inc. Pneumonia Vaccine Product Market Performance
9.7.4 Astellas Pharma Inc. Business Overview
9.7.5 Astellas Pharma Inc. Recent Developments
9.8 Astrazeneca Plc.
9.8.1 Astrazeneca Plc. Pneumonia Vaccine Basic Information
9.8.2 Astrazeneca Plc. Pneumonia Vaccine Product Overview
9.8.3 Astrazeneca Plc. Pneumonia Vaccine Product Market Performance
9.8.4 Astrazeneca Plc. Business Overview
9.8.5 Astrazeneca Plc. Recent Developments
9.9 CSL Limited
9.9.1 CSL Limited Pneumonia Vaccine Basic Information
9.9.2 CSL Limited Pneumonia Vaccine Product Overview
9.9.3 CSL Limited Pneumonia Vaccine Product Market Performance
9.9.4 CSL Limited Business Overview
9.9.5 CSL Limited Recent Developments
9.10 Emergent Biosolutions
9.10.1 Emergent Biosolutions Pneumonia Vaccine Basic Information
9.10.2 Emergent Biosolutions Pneumonia Vaccine Product Overview
9.10.3 Emergent Biosolutions Pneumonia Vaccine Product Market Performance
9.10.4 Emergent Biosolutions Business Overview
9.10.5 Emergent Biosolutions Recent Developments
9.11 Walvax Biotechnology
9.11.1 Walvax Biotechnology Pneumonia Vaccine Basic Information
9.11.2 Walvax Biotechnology Pneumonia Vaccine Product Overview
9.11.3 Walvax Biotechnology Pneumonia Vaccine Product Market Performance
9.11.4 Walvax Biotechnology Business Overview
9.11.5 Walvax Biotechnology Recent Developments
9.12 Royal (Wuxi) Bio-Pharmaceutical
9.12.1 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Basic Information
9.12.2 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Overview
9.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Market Performance
9.12.4 Royal (Wuxi) Bio-Pharmaceutical Business Overview
9.12.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
9.13 Zhifei Biologic
9.13.1 Zhifei Biologic Pneumonia Vaccine Basic Information
9.13.2 Zhifei Biologic Pneumonia Vaccine Product Overview
9.13.3 Zhifei Biologic Pneumonia Vaccine Product Market Performance
9.13.4 Zhifei Biologic Business Overview
9.13.5 Zhifei Biologic Recent Developments
10 PNEUMONIA VACCINE MARKET FORECAST BY REGION
10.1 Global Pneumonia Vaccine Market Size Forecast
10.2 Global Pneumonia Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pneumonia Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Pneumonia Vaccine Market Size Forecast by Region
10.2.4 South America Pneumonia Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pneumonia Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Pneumonia Vaccine Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Pneumonia Vaccine by Type (2024-2029)
11.1.2 Global Pneumonia Vaccine Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Pneumonia Vaccine by Type (2024-2029)
11.2 Global Pneumonia Vaccine Market Forecast by Application (2024-2029)
11.2.1 Global Pneumonia Vaccine Sales (K MT) Forecast by Application
11.2.2 Global Pneumonia Vaccine Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pneumonia Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Pneumonia Vaccine Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global Pneumonia Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Pneumonia Vaccine Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Pneumonia Vaccine Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Vaccine as of 2022)
Table 10. Global Market Pneumonia Vaccine Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Pneumonia Vaccine Sales Sites and Area Served
Table 12. Manufacturers Pneumonia Vaccine Product Type
Table 13. Global Pneumonia Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pneumonia Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pneumonia Vaccine Market Challenges
Table 22. Market Restraints
Table 23. Global Pneumonia Vaccine Sales by Type (K MT)
Table 24. Global Pneumonia Vaccine Market Size by Type (M USD)
Table 25. Global Pneumonia Vaccine Sales (K MT) by Type (2018-2023)
Table 26. Global Pneumonia Vaccine Sales Market Share by Type (2018-2023)
Table 27. Global Pneumonia Vaccine Market Size (M USD) by Type (2018-2023)
Table 28. Global Pneumonia Vaccine Market Size Share by Type (2018-2023)
Table 29. Global Pneumonia Vaccine Price (USD/MT) by Type (2018-2023)
Table 30. Global Pneumonia Vaccine Sales (K MT) by Application
Table 31. Global Pneumonia Vaccine Market Size by Application
Table 32. Global Pneumonia Vaccine Sales by Application (2018-2023) & (K MT)
Table 33. Global Pneumonia Vaccine Sales Market Share by Application (2018-2023)
Table 34. Global Pneumonia Vaccine Sales by Application (2018-2023) & (M USD)
Table 35. Global Pneumonia Vaccine Market Share by Application (2018-2023)
Table 36. Global Pneumonia Vaccine Sales Growth Rate by Application (2018-2023)
Table 37. Global Pneumonia Vaccine Sales by Region (2018-2023) & (K MT)
Table 38. Global Pneumonia Vaccine Sales Market Share by Region (2018-2023)
Table 39. North America Pneumonia Vaccine Sales by Country (2018-2023) & (K MT)
Table 40. Europe Pneumonia Vaccine Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific Pneumonia Vaccine Sales by Region (2018-2023) & (K MT)
Table 42. South America Pneumonia Vaccine Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa Pneumonia Vaccine Sales by Region (2018-2023) & (K MT)
Table 44. Pfizer Inc. Pneumonia Vaccine Basic Information
Table 45. Pfizer Inc. Pneumonia Vaccine Product Overview
Table 46. Pfizer Inc. Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Pfizer Inc. Business Overview
Table 48. Pfizer Inc. Pneumonia Vaccine SWOT Analysis
Table 49. Pfizer Inc. Recent Developments
Table 50. Glaxosmithkline Plc. Pneumonia Vaccine Basic Information
Table 51. Glaxosmithkline Plc. Pneumonia Vaccine Product Overview
Table 52. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Glaxosmithkline Plc. Business Overview
Table 54. Glaxosmithkline Plc. Pneumonia Vaccine SWOT Analysis
Table 55. Glaxosmithkline Plc. Recent Developments
Table 56. Merck and Co., Inc. Pneumonia Vaccine Basic Information
Table 57. Merck and Co., Inc. Pneumonia Vaccine Product Overview
Table 58. Merck and Co., Inc. Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Merck and Co., Inc. Business Overview
Table 60. Merck and Co., Inc. Pneumonia Vaccine SWOT Analysis
Table 61. Merck and Co., Inc. Recent Developments
Table 62. Sanofi Pasteur Pneumonia Vaccine Basic Information
Table 63. Sanofi Pasteur Pneumonia Vaccine Product Overview
Table 64. Sanofi Pasteur Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Sanofi Pasteur Business Overview
Table 66. Sanofi Pasteur Pneumonia Vaccine SWOT Analysis
Table 67. Sanofi Pasteur Recent Developments
Table 68. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Basic Information
Table 69. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Overview
Table 70. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. Serum Institute of India Pvt. Ltd. Business Overview
Table 72. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine SWOT Analysis
Table 73. Serum Institute of India Pvt. Ltd. Recent Developments
Table 74. Johnson and Johnson Pneumonia Vaccine Basic Information
Table 75. Johnson and Johnson Pneumonia Vaccine Product Overview
Table 76. Johnson and Johnson Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. Johnson and Johnson Business Overview
Table 78. Johnson and Johnson Recent Developments
Table 79. Astellas Pharma Inc. Pneumonia Vaccine Basic Information
Table 80. Astellas Pharma Inc. Pneumonia Vaccine Product Overview
Table 81. Astellas Pharma Inc. Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Astellas Pharma Inc. Business Overview
Table 83. Astellas Pharma Inc. Recent Developments
Table 84. Astrazeneca Plc. Pneumonia Vaccine Basic Information
Table 85. Astrazeneca Plc. Pneumonia Vaccine Product Overview
Table 86. Astrazeneca Plc. Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Astrazeneca Plc. Business Overview
Table 88. Astrazeneca Plc. Recent Developments
Table 89. CSL Limited Pneumonia Vaccine Basic Information
Table 90. CSL Limited Pneumonia Vaccine Product Overview
Table 91. CSL Limited Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. CSL Limited Business Overview
Table 93. CSL Limited Recent Developments
Table 94. Emergent Biosolutions Pneumonia Vaccine Basic Information
Table 95. Emergent Biosolutions Pneumonia Vaccine Product Overview
Table 96. Emergent Biosolutions Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Emergent Biosolutions Business Overview
Table 98. Emergent Biosolutions Recent Developments
Table 99. Walvax Biotechnology Pneumonia Vaccine Basic Information
Table 100. Walvax Biotechnology Pneumonia Vaccine Product Overview
Table 101. Walvax Biotechnology Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Walvax Biotechnology Business Overview
Table 103. Walvax Biotechnology Recent Developments
Table 104. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Basic Information
Table 105. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Overview
Table 106. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Royal (Wuxi) Bio-Pharmaceutical Business Overview
Table 108. Royal (Wuxi) Bio-Pharmaceutical Recent Developments
Table 109. Zhifei Biologic Pneumonia Vaccine Basic Information
Table 110. Zhifei Biologic Pneumonia Vaccine Product Overview
Table 111. Zhifei Biologic Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. Zhifei Biologic Business Overview
Table 113. Zhifei Biologic Recent Developments
Table 114. Global Pneumonia Vaccine Sales Forecast by Region (2024-2029) & (K MT)
Table 115. Global Pneumonia Vaccine Market Size Forecast by Region (2024-2029) & (M USD)
Table 116. North America Pneumonia Vaccine Sales Forecast by Country (2024-2029) & (K MT)
Table 117. North America Pneumonia Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 118. Europe Pneumonia Vaccine Sales Forecast by Country (2024-2029) & (K MT)
Table 119. Europe Pneumonia Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 120. Asia Pacific Pneumonia Vaccine Sales Forecast by Region (2024-2029) & (K MT)
Table 121. Asia Pacific Pneumonia Vaccine Market Size Forecast by Region (2024-2029) & (M USD)
Table 122. South America Pneumonia Vaccine Sales Forecast by Country (2024-2029) & (K MT)
Table 123. South America Pneumonia Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 124. Middle East and Africa Pneumonia Vaccine Consumption Forecast by Country (2024-2029) & (Units)
Table 125. Middle East and Africa Pneumonia Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 126. Global Pneumonia Vaccine Sales Forecast by Type (2024-2029) & (K MT)
Table 127. Global Pneumonia Vaccine Market Size Forecast by Type (2024-2029) & (M USD)
Table 128. Global Pneumonia Vaccine Price Forecast by Type (2024-2029) & (USD/MT)
Table 129. Global Pneumonia Vaccine Sales (K MT) Forecast by Application (2024-2029)
Table 130. Global Pneumonia Vaccine Market Size Forecast by Application (2024-2029) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pneumonia Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Pneumonia Vaccine Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global Pneumonia Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Pneumonia Vaccine Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Pneumonia Vaccine Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Vaccine as of 2022)
Table 10. Global Market Pneumonia Vaccine Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Pneumonia Vaccine Sales Sites and Area Served
Table 12. Manufacturers Pneumonia Vaccine Product Type
Table 13. Global Pneumonia Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pneumonia Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pneumonia Vaccine Market Challenges
Table 22. Market Restraints
Table 23. Global Pneumonia Vaccine Sales by Type (K MT)
Table 24. Global Pneumonia Vaccine Market Size by Type (M USD)
Table 25. Global Pneumonia Vaccine Sales (K MT) by Type (2018-2023)
Table 26. Global Pneumonia Vaccine Sales Market Share by Type (2018-2023)
Table 27. Global Pneumonia Vaccine Market Size (M USD) by Type (2018-2023)
Table 28. Global Pneumonia Vaccine Market Size Share by Type (2018-2023)
Table 29. Global Pneumonia Vaccine Price (USD/MT) by Type (2018-2023)
Table 30. Global Pneumonia Vaccine Sales (K MT) by Application
Table 31. Global Pneumonia Vaccine Market Size by Application
Table 32. Global Pneumonia Vaccine Sales by Application (2018-2023) & (K MT)
Table 33. Global Pneumonia Vaccine Sales Market Share by Application (2018-2023)
Table 34. Global Pneumonia Vaccine Sales by Application (2018-2023) & (M USD)
Table 35. Global Pneumonia Vaccine Market Share by Application (2018-2023)
Table 36. Global Pneumonia Vaccine Sales Growth Rate by Application (2018-2023)
Table 37. Global Pneumonia Vaccine Sales by Region (2018-2023) & (K MT)
Table 38. Global Pneumonia Vaccine Sales Market Share by Region (2018-2023)
Table 39. North America Pneumonia Vaccine Sales by Country (2018-2023) & (K MT)
Table 40. Europe Pneumonia Vaccine Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific Pneumonia Vaccine Sales by Region (2018-2023) & (K MT)
Table 42. South America Pneumonia Vaccine Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa Pneumonia Vaccine Sales by Region (2018-2023) & (K MT)
Table 44. Pfizer Inc. Pneumonia Vaccine Basic Information
Table 45. Pfizer Inc. Pneumonia Vaccine Product Overview
Table 46. Pfizer Inc. Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Pfizer Inc. Business Overview
Table 48. Pfizer Inc. Pneumonia Vaccine SWOT Analysis
Table 49. Pfizer Inc. Recent Developments
Table 50. Glaxosmithkline Plc. Pneumonia Vaccine Basic Information
Table 51. Glaxosmithkline Plc. Pneumonia Vaccine Product Overview
Table 52. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Glaxosmithkline Plc. Business Overview
Table 54. Glaxosmithkline Plc. Pneumonia Vaccine SWOT Analysis
Table 55. Glaxosmithkline Plc. Recent Developments
Table 56. Merck and Co., Inc. Pneumonia Vaccine Basic Information
Table 57. Merck and Co., Inc. Pneumonia Vaccine Product Overview
Table 58. Merck and Co., Inc. Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Merck and Co., Inc. Business Overview
Table 60. Merck and Co., Inc. Pneumonia Vaccine SWOT Analysis
Table 61. Merck and Co., Inc. Recent Developments
Table 62. Sanofi Pasteur Pneumonia Vaccine Basic Information
Table 63. Sanofi Pasteur Pneumonia Vaccine Product Overview
Table 64. Sanofi Pasteur Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Sanofi Pasteur Business Overview
Table 66. Sanofi Pasteur Pneumonia Vaccine SWOT Analysis
Table 67. Sanofi Pasteur Recent Developments
Table 68. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Basic Information
Table 69. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Overview
Table 70. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. Serum Institute of India Pvt. Ltd. Business Overview
Table 72. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine SWOT Analysis
Table 73. Serum Institute of India Pvt. Ltd. Recent Developments
Table 74. Johnson and Johnson Pneumonia Vaccine Basic Information
Table 75. Johnson and Johnson Pneumonia Vaccine Product Overview
Table 76. Johnson and Johnson Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. Johnson and Johnson Business Overview
Table 78. Johnson and Johnson Recent Developments
Table 79. Astellas Pharma Inc. Pneumonia Vaccine Basic Information
Table 80. Astellas Pharma Inc. Pneumonia Vaccine Product Overview
Table 81. Astellas Pharma Inc. Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Astellas Pharma Inc. Business Overview
Table 83. Astellas Pharma Inc. Recent Developments
Table 84. Astrazeneca Plc. Pneumonia Vaccine Basic Information
Table 85. Astrazeneca Plc. Pneumonia Vaccine Product Overview
Table 86. Astrazeneca Plc. Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Astrazeneca Plc. Business Overview
Table 88. Astrazeneca Plc. Recent Developments
Table 89. CSL Limited Pneumonia Vaccine Basic Information
Table 90. CSL Limited Pneumonia Vaccine Product Overview
Table 91. CSL Limited Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. CSL Limited Business Overview
Table 93. CSL Limited Recent Developments
Table 94. Emergent Biosolutions Pneumonia Vaccine Basic Information
Table 95. Emergent Biosolutions Pneumonia Vaccine Product Overview
Table 96. Emergent Biosolutions Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Emergent Biosolutions Business Overview
Table 98. Emergent Biosolutions Recent Developments
Table 99. Walvax Biotechnology Pneumonia Vaccine Basic Information
Table 100. Walvax Biotechnology Pneumonia Vaccine Product Overview
Table 101. Walvax Biotechnology Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Walvax Biotechnology Business Overview
Table 103. Walvax Biotechnology Recent Developments
Table 104. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Basic Information
Table 105. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Overview
Table 106. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Royal (Wuxi) Bio-Pharmaceutical Business Overview
Table 108. Royal (Wuxi) Bio-Pharmaceutical Recent Developments
Table 109. Zhifei Biologic Pneumonia Vaccine Basic Information
Table 110. Zhifei Biologic Pneumonia Vaccine Product Overview
Table 111. Zhifei Biologic Pneumonia Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. Zhifei Biologic Business Overview
Table 113. Zhifei Biologic Recent Developments
Table 114. Global Pneumonia Vaccine Sales Forecast by Region (2024-2029) & (K MT)
Table 115. Global Pneumonia Vaccine Market Size Forecast by Region (2024-2029) & (M USD)
Table 116. North America Pneumonia Vaccine Sales Forecast by Country (2024-2029) & (K MT)
Table 117. North America Pneumonia Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 118. Europe Pneumonia Vaccine Sales Forecast by Country (2024-2029) & (K MT)
Table 119. Europe Pneumonia Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 120. Asia Pacific Pneumonia Vaccine Sales Forecast by Region (2024-2029) & (K MT)
Table 121. Asia Pacific Pneumonia Vaccine Market Size Forecast by Region (2024-2029) & (M USD)
Table 122. South America Pneumonia Vaccine Sales Forecast by Country (2024-2029) & (K MT)
Table 123. South America Pneumonia Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 124. Middle East and Africa Pneumonia Vaccine Consumption Forecast by Country (2024-2029) & (Units)
Table 125. Middle East and Africa Pneumonia Vaccine Market Size Forecast by Country (2024-2029) & (M USD)
Table 126. Global Pneumonia Vaccine Sales Forecast by Type (2024-2029) & (K MT)
Table 127. Global Pneumonia Vaccine Market Size Forecast by Type (2024-2029) & (M USD)
Table 128. Global Pneumonia Vaccine Price Forecast by Type (2024-2029) & (USD/MT)
Table 129. Global Pneumonia Vaccine Sales (K MT) Forecast by Application (2024-2029)
Table 130. Global Pneumonia Vaccine Market Size Forecast by Application (2024-2029) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pneumonia Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pneumonia Vaccine Market Size (M USD), 2018-2029
Figure 5. Global Pneumonia Vaccine Market Size (M USD) (2018-2029)
Figure 6. Global Pneumonia Vaccine Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pneumonia Vaccine Market Size by Country (M USD)
Figure 11. Pneumonia Vaccine Sales Share by Manufacturers in 2022
Figure 12. Global Pneumonia Vaccine Revenue Share by Manufacturers in 2022
Figure 13. Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Pneumonia Vaccine Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pneumonia Vaccine Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pneumonia Vaccine Market Share by Type
Figure 18. Sales Market Share of Pneumonia Vaccine by Type (2018-2023)
Figure 19. Sales Market Share of Pneumonia Vaccine by Type in 2022
Figure 20. Market Size Share of Pneumonia Vaccine by Type (2018-2023)
Figure 21. Market Size Market Share of Pneumonia Vaccine by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pneumonia Vaccine Market Share by Application
Figure 24. Global Pneumonia Vaccine Sales Market Share by Application (2018-2023)
Figure 25. Global Pneumonia Vaccine Sales Market Share by Application in 2022
Figure 26. Global Pneumonia Vaccine Market Share by Application (2018-2023)
Figure 27. Global Pneumonia Vaccine Market Share by Application in 2022
Figure 28. Global Pneumonia Vaccine Sales Growth Rate by Application (2018-2023)
Figure 29. Global Pneumonia Vaccine Sales Market Share by Region (2018-2023)
Figure 30. North America Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America Pneumonia Vaccine Sales Market Share by Country in 2022
Figure 32. U.S. Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada Pneumonia Vaccine Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico Pneumonia Vaccine Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe Pneumonia Vaccine Sales Market Share by Country in 2022
Figure 37. Germany Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific Pneumonia Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Pneumonia Vaccine Sales Market Share by Region in 2022
Figure 44. China Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America Pneumonia Vaccine Sales and Growth Rate (K MT)
Figure 50. South America Pneumonia Vaccine Sales Market Share by Country in 2022
Figure 51. Brazil Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa Pneumonia Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Pneumonia Vaccine Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global Pneumonia Vaccine Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global Pneumonia Vaccine Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Pneumonia Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Pneumonia Vaccine Market Share Forecast by Type (2024-2029)
Figure 65. Global Pneumonia Vaccine Sales Forecast by Application (2024-2029)
Figure 66. Global Pneumonia Vaccine Market Share Forecast by Application (2024-2029)
Figure 1. Product Picture of Pneumonia Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pneumonia Vaccine Market Size (M USD), 2018-2029
Figure 5. Global Pneumonia Vaccine Market Size (M USD) (2018-2029)
Figure 6. Global Pneumonia Vaccine Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pneumonia Vaccine Market Size by Country (M USD)
Figure 11. Pneumonia Vaccine Sales Share by Manufacturers in 2022
Figure 12. Global Pneumonia Vaccine Revenue Share by Manufacturers in 2022
Figure 13. Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Pneumonia Vaccine Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pneumonia Vaccine Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pneumonia Vaccine Market Share by Type
Figure 18. Sales Market Share of Pneumonia Vaccine by Type (2018-2023)
Figure 19. Sales Market Share of Pneumonia Vaccine by Type in 2022
Figure 20. Market Size Share of Pneumonia Vaccine by Type (2018-2023)
Figure 21. Market Size Market Share of Pneumonia Vaccine by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pneumonia Vaccine Market Share by Application
Figure 24. Global Pneumonia Vaccine Sales Market Share by Application (2018-2023)
Figure 25. Global Pneumonia Vaccine Sales Market Share by Application in 2022
Figure 26. Global Pneumonia Vaccine Market Share by Application (2018-2023)
Figure 27. Global Pneumonia Vaccine Market Share by Application in 2022
Figure 28. Global Pneumonia Vaccine Sales Growth Rate by Application (2018-2023)
Figure 29. Global Pneumonia Vaccine Sales Market Share by Region (2018-2023)
Figure 30. North America Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America Pneumonia Vaccine Sales Market Share by Country in 2022
Figure 32. U.S. Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada Pneumonia Vaccine Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico Pneumonia Vaccine Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe Pneumonia Vaccine Sales Market Share by Country in 2022
Figure 37. Germany Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific Pneumonia Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Pneumonia Vaccine Sales Market Share by Region in 2022
Figure 44. China Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America Pneumonia Vaccine Sales and Growth Rate (K MT)
Figure 50. South America Pneumonia Vaccine Sales Market Share by Country in 2022
Figure 51. Brazil Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa Pneumonia Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Pneumonia Vaccine Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa Pneumonia Vaccine Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global Pneumonia Vaccine Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global Pneumonia Vaccine Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Pneumonia Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Pneumonia Vaccine Market Share Forecast by Type (2024-2029)
Figure 65. Global Pneumonia Vaccine Sales Forecast by Application (2024-2029)
Figure 66. Global Pneumonia Vaccine Market Share Forecast by Application (2024-2029)
